首頁 > 市場調查報告書 > 製藥

疫苗

市場調查報告書

商品編碼

1378596

治療性蛋白質和口服疫苗市場：按藥物類別、按應用、按配銷通路、按地區

Therapeutic Proteins And Oral Vaccines Market, By Drug Class (Therapeutic Proteins, Oral Vaccines ), By Application, By Distribution Channel, By Geography

出版日期: 2023年10月12日 | 出版商:

Coherent Market Insights | 英文 178 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023年，全球治療性蛋白質和口服疫苗市場估計為2.467億美元，預計在預測期內（2023-2030年）年複合成長率為8.1%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	2.467 億美元
實績資料	2018-2021	預測期	2023-2030
預測期年複合成長率	8.10%	2030年市場規模預測	4.248 億美元

圖 1. 2023 年治療性蛋白質和口服疫苗的全球市場佔有率（按藥物類別分類）

治療性蛋白質是臨床上使用生物製藥的主要選擇之一。蛋白質是具有大分子量的有機化合物。它對癌症、後天免疫力缺乏症候群（愛滋病）和各種感染疾病具有治療作用。當蛋白質用於治療目的時，它被稱為治療性蛋白質。治療性蛋白質是在實驗室中出於製藥目的而操作的蛋白質，用於生產治療糖尿病的胰島素。治療性蛋白質在體內非常有效，並徹底改變了疾病治療。與任何其他疫苗接種途徑相比，口服免疫被認為是最方便的疫苗接種途徑，因為它比傳統疫苗配備更好。透過口服疫苗獲得黏膜免疫，可以作為人與人或動物與人之間病原體性行為感染的保護劑，也可以保護黏膜區域免受病原體的侵害，這是微生物進入人體血液循環的最優選途徑。能抑制有性複製。

市場動態

治療性蛋白質和口服疫苗市場的主要參與者專注於疫苗和產品開發以及市場參與者的研究和開發。因此，將此類先進產品引入市場預計將在預測期內推動全球治療性蛋白質和口服疫苗市場的成長。例如，2022 年 9 月，臨床階段生物技術公司 Vaxart, Inc. 宣布計分類兩部分進行其武漢 S專用錠劑COVID-19 候選疫苗VXA-CoV2-1.1-S 的II 期試驗。報告了良好的頂線資料從審判的第一部分開始。這些資料表明該研究達到了主要安全性和次要免疫抗原性原性終點，並將支持基於 Omicron 的新疫苗結構的持續開發。

本次測試的主要特點

該報告詳細分析了全球治療性蛋白質和口服疫苗市場，並提供了以 2022 年為基準年的預測期（2023-2030）的市場規模。
它揭示了各個細分市場的潛在商機，並說明了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
它根據公司亮點、產品系列、主要亮點、績效和策略等參數，介紹了全球治療性蛋白質和口服疫苗市場的主要企業。
該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的資訊。
全球治療性蛋白質和口服疫苗市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球治療性蛋白質和口服疫苗市場的各種策略矩陣來促進他們的決策。

公司簡介
- Abbott Laboratories
- Amgen, Inc.
- Biogen, Inc.
- Eli Lilly and Company
- F. Hoffmann-La Roche AG
- Johnson and Johnson
- Merck &Co. Inc.
- Novo Nordisk A/S
- Pfizer, Inc.
- Sanofi SA
- Serum Institute of India Pvt. Ltd.
- Emergent Biosolutions Inc.
- TransAlgae
- MigVax Ltd.
- Lumen Bioscience, Inc.

第10章章

參考
調查方法

簡介目錄

Product Code: CMI4396

The Global Therapeutic Proteins And Oral Vaccines Market is estimated to be valued at US$ 246.7 Mn in 2023 and is expected to exhibit a CAGR of 8.1% during the forecast period (2023-2030).

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 246.7 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	8.10%	2030 Value Projection:	US$ 424.8 Mn

Figure 1. Global Therapeutic Proteins and Oral Vaccines Market Share (%), By Drug Class, 2023

Therapeutic Proteins And Oral Vaccines Market - IMG1

Therapeutic proteins are one of the prime options for biologicals as per their clinical uses. Proteins are organic compounds with a higher molecular weight. This have therapeutic effects against various diseases like cancer, Acquired immunodeficiency syndrome (AIDS), and various infectious diseases. When protein is used for therapeutic purposes, it is known as a therapeutic protein. Therapeutic proteins are proteins that are engineered in the laboratory for pharmaceutical purposes in the making of insulin to treat diabetes. Therapeutic proteins are highly effective in vivo and have revolutionized the treatment of diseases. Oral immunization is considered the most convenient route of vaccination rather than any other route due to its abundance of facilities over the traditional vaccines. Gaining of mucosal immunity through oral vaccination can act as a protector against human-to-human or animal-to-human pathogenic transmission of diseases and also inhibit the pathogenic replication in the mucosal area which is the most preferable able route of microbe's penetration to the host blood circulation.

Market Dynamics

The key players in the therapeutic proteins and oral vaccines market are focusing on the development of vaccines, products, and research and development by market players. Thus, the introduction of such advanced products into the market is expected to drive growth of the global therapeutic proteins and oral vaccines market over the forecast period. For instance, in September 2022, Vaxart, Inc., a clinical-stage biotechnology company, reported positive top-line data from the first part of a planned two-part Phase II study of its Wuhan S-only oral pill COVID-19 vaccine candidate, VXA-CoV2-1.1-S. The data demonstrate that the trial met its primary safety and secondary immunogenicity endpoints and will inform the ongoing development of new Omicron-based vaccine constructs.

Key features of the study:

This report provides an in-depth analysis of the global therapeutic proteins and oral vaccines market and provides market size (US$ Mn and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global global therapeutic proteins and oral vaccines market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Abbott Laboratories, Amgen, Inc., Biogen, Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG, Johnson and Johnson, Merck & Co.Inc., Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., Serum Institute of India Pvt. Ltd., Emergent Biosolutions Inc., TransAlgae, MigVax Ltd., and Lumen Bioscience, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global therapeutic proteins and oral vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global therapeutic proteins and oral vaccines market

Therapeutic Proteins And Oral Vaccines Market Detailed Segmentation:

By Drug Class:
- Therapeutic Proteins
- Growth Factors
- Fusion Proteins
- Monoclonal Antibodies
- Hormones
- Coagulation Factors
- Others
- Oral Vaccines
- Live Attenuated Vaccine
- Inactivated Vaccine
- Recombinant Vaccine
- Others
By Application:
- Oncology
- Hematology
- Immunology
- Endocrinology
- Infectious Disease
- Cardiovascular Disease
- Others
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Company Profiles
- Abbott Laboratories
- Amgen, Inc.
- Biogen, Inc.
- Eli Lilly and Company
- F. Hoffmann-La Roche AG
- Johnson and Johnson
- Merck & Co.Inc.
- Novo Nordisk A/S
- Pfizer, Inc.
- Sanofi S.A.
- Serum Institute of India Pvt. Ltd.
- Emergent Biosolutions Inc.
- TransAlgae
- MigVax Ltd.
- Lumen Bioscience, Inc.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Test Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Therapeutic Proteins and Oral Vaccines Market - COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Therapeutic Proteins and Oral Vaccines Market, By Drug Class, 2018- 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Therapeutic Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Segment Trends
Growth Factors
Fusion Proteins
Monoclonal Antibodies
Hormones
Coagulation Factors
Others
Oral Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Segment Trends
Live Attenuated Vaccine
Inactivated Vaccine
Recombinant Vaccine
Others

6. Global Therapeutic Proteins and Oral Vaccines Market, By Application, 2018 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Segment Trends
Hematology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Segment Trends
Immunology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Segment Trends
Endocrinology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Segment Trends
Infectious Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Segment Trends
Cardiovascular Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Segment Trends

7. Global Therapeutic Proteins and Oral Vaccines Market, By Distribution Channel, 2018 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

8. Global Therapeutic Proteins and Oral Vaccines Market, By Region, 2018 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Drug Class, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Drug Class, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Country/Region, 2018 -2030, (US$ Mn)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Company Profiles
- Abbott Laboratories
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Amgen, Inc.
- Biogen, Inc.
- Eli Lilly and Company
- F. Hoffmann-La Roche AG
- Johnson and Johnson
- Merck & Co. Inc.
- Novo Nordisk A/S
- Pfizer, Inc.
- Sanofi S.A.
- Serum Institute of India Pvt. Ltd.
- Emergent Biosolutions Inc.
- TransAlgae
- MigVax Ltd.
- Lumen Bioscience, Inc.